* Solara Active Pharma Sciences Limited announces the successful closure of the US FDA inspection of its Mangalore facility. * The inspection, conducted from 25th to 29th Aug 2025, resulted in the facility being classified as "Voluntary Action Indicated (VAI)". * The Establishment Inspection Report (EIR) was issued on 18th Nov 2025. * Two Form FDA 483 inspectional observations, procedural in nature, were issued during the inspection, and Solara responded within the agency's timeline. * Sandeep Rao, MD & CEO, stated that the outcome demonstrates the company's commitment to regulatory excellence and focus on quality and compliance.
